UAE Pharmaceutical Market Overview:
The UAE pharmaceutical market is projected to exhibit a growth rate (CAGR) of 6.7% during 2024-2032 There are various factors that are driving the market, which include rising health awareness initiatives, increasing geriatric population, favorable government initiatives, advanced healthcare infrastructure, and various technological advancements.
Report Attribute
|
Key Statistics
|
Base Year
|
2023 |
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate (2024-2032) |
6.7% |
UAE Pharmaceutical Market Trends:
Rising Health Awareness Initiatives
Pfizer launched a thorough education effort in the United Arab Emirates on 1 May 2024 to generate awareness about respiratory syncytial virus (RSV) and preventative actions that can be performed. Pfizer organized an educational media roundtable with the assistance of medical experts aimed to highlight the importance of RSV prevention as well as the disease's impact and symptoms. The company is trying to find and create medications that could protect people from specific illnesses. Health awareness initiatives like these are catalyzing the demand for pharmaceutical drugs in the UAE. These initiatives, driven by both government and private sector efforts, aim to educate the population about health issues, promote preventive care, and encourage healthy lifestyles. Furthermore, regular health screenings and preventive programs are promoted to detect diseases early and manage them effectively. Campaigns to increase vaccination coverage for various diseases contribute to better public health and increased pharmaceutical demand.
Increasing Geriatric Population
The older population is more likely to suffer from chronic illnesses, including diabetes, cancer, and cardiovascular problems, which is driving the demand for medicines and favorably impacting the industry. Chronic illnesses that necessitate continuous medical attention and pharmaceutical administration are increasingly common in the aged population. The elderly population tends to use healthcare services more frequently including hospital visits, regular check-ups, and specialist consultations. This increased utilization leads to higher prescription rates and medication adherence, thereby increasing pharmaceutical sales. Besides this, the wide availability of advanced medical treatments and technologies tailored for the elderly population catalyze the demand for pharmaceuticals. Major players in the market are focusing on providing more advanced drugs that are specially developed to cater to the needs of elderly individuals. The United Nations Fund for Population Activities (UNFPA) reports that the number of persons aged 60+ is anticipated to increase more than six-fold between 2020 to 2050 from around 311,000 to 2 Million.
UAE Pharmaceutical Market News:
- 23 April 2024: Two medications, Ninervilda-50 (vildagliptin 50 mg) and Vertephin (verteporfin), were introduced by Niner Pharmaceuticals LLC, a well-known pharmaceutical company. These drugs are intended to treat serious blood vessel diseases in the eye. These innovations are set to upgrade the treatment of macular degeneration and other related diseases in the UAE, Saudi Arabia, and Latino-American countries.
- 30 October 2023: Pfizer, Middle East, Russia and Africa (MERA) hosted the MERA Vaccines Summit and welcomed more than 100 physicians and healthcare professionals from around the region to Dubai, UAE. The event covered a range of communicable diseases with leading experts. International and regional experts highlighted the global and regional burden of disease and the public health impact of vaccination and summarized recommendations for vaccination for various patient populations.
UAE Pharmaceutical Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type and nature.
Type Insights:
- Pharmaceutical Drugs
- Cardiovascular Drugs
- Dermatology Drugs
- Gastrointestinal Drugs
- Genito-Urinary Drugs
- Hematology Drugs
- Anti-Infective Drugs
- Metabolic Disorder Drugs
- Musculoskeletal Disorder Drugs
- Central Nervous System Drugs
- Oncology Drugs
- Ophthalmology Drugs
- Respiratory Diseases Drugs
- Biologics
- Monoclonal Antibodies (MAbS)
- Therapeutic Proteins
- Vaccines
The report has provided a detailed breakup and analysis of the market based on the type. This includes pharmaceutical drugs (cardiovascular, dermatology, gastrointestinal, genito-urinary, hematology, anti-infective, metabolic disorder, musculoskeletal disorder, central nervous system, oncology, ophthalmology, and respiratory diseases drugs) and biologics (monoclonal antibodies (MAbS), therapeutic proteins, and vaccines).
Nature Insights:
A detailed breakup and analysis of the market based on the nature have also been provided in the report. This includes organic and conventional.
Regional Insights:
- Dubai
- Abu Dhabi
- Sharjah
- Others
The report has also provided a comprehensive analysis of all the major regional markets, which include Dubai, Abu Dhabi, Sharjah, and Others.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
UAE Pharmaceutical Market Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
Billion US$ |
Scope of the Report |
Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Types Covered |
- Pharmaceutical Drugs: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs
- Biologics: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
|
Natures Covered |
Organic, Conventional |
Regions Covered |
Dubai, Abu Dhabi, Sharjah, Others |
Customization Scope |
10% Free Customization |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the UAE pharmaceutical market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the UAE pharmaceutical market?
- What is the breakup of the UAE pharmaceutical market on the basis of type?
- What is the breakup of the UAE pharmaceutical market on the basis of nature?
- What are the various stages in the value chain of the UAE pharmaceutical market?
- What are the key driving factors and challenges in the UAE pharmaceutical?
- What is the structure of the UAE pharmaceutical market and who are the key players?
- What is the degree of competition in the UAE pharmaceutical market?
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the UAE pharmaceutical market from 2018-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the UAE pharmaceutical market.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the UAE pharmaceutical industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.